The Wistar Institute of Philadelphia Signs Agreement With DavosPharma
DavosPharma recently announced it has signed a collaborative agreement with The Wistar Institute of Philadelphia. This agreement provides DMPK, and preclinical
Since 1972, DavosPharma has serviced the pharmaceutical industry, from preclinical development to commercialization. Over the years, the company has established an excellent reputation in evaluating, coordinating, and delivering drug development through strategic partners. DavosPharma is headquartered in
The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent nonprofit biomedical research institute in the country, Wistar has long held the prestigious
Total Page Views: 1161
